Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers
- PMID: 18030450
- DOI: 10.1007/s00213-007-0963-0
Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers
Abstract
Objectives: Ayahuasca is a traditional South American psychoactive beverage and the central sacrament of Brazilian-based religious groups, with followers in Europe and the United States. The tea contains the psychedelic indole N,N-dimethyltryptamine (DMT) and beta-carboline alkaloids with monoamine oxidase-inhibiting properties that render DMT orally active. DMT interacts with serotonergic neurotransmission acting as a partial agonist at 5-HT(1A) and 5-HT(2A/2C) receptor sites. Given the role played by serotonin in the regulation of the sleep/wake cycle, we investigated the effects of daytime ayahuasca consumption in sleep parameters.
Measurements and results: Subjective sleep quality, polysomnography (PSG), and spectral analysis were assessed in a group of 22 healthy male volunteers after the administration of a placebo, an ayahuasca dose equivalent to 1 mg DMT kg(-1) body weight, and 20 mg d-amphetamine, a proaminergic drug, as a positive control. Results show that ayahuasca did not induce any subjectively perceived deterioration of sleep quality or PSG-measured disruptions of sleep initiation or maintenance, in contrast with d-amphetamine, which delayed sleep initiation, disrupted sleep maintenance, induced a predominance of 'light' vs 'deep' sleep and significantly impaired subjective sleep quality. PSG analysis also showed that similarly to d-amphetamine, ayahuasca inhibits rapid eye movement (REM) sleep, decreasing its duration, both in absolute values and as a percentage of total sleep time, and shows a trend increase in its onset latency. Spectral analysis showed that d-amphetamine and ayahuasca increased power in the high frequency range, mainly during stage 2. Remarkably, whereas slow-wave sleep (SWS) power in the first night cycle, an indicator of sleep pressure, was decreased by d-amphetamine, ayahuasca enhanced power in this frequency band.
Conclusions: Results show that daytime serotonergic psychedelic drug administration leads to measurable changes in PSG and sleep power spectrum and suggest an interaction between these drugs and brain circuits modulating REM and SWS.
Similar articles
-
Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.J Clin Psychopharmacol. 2011 Dec;31(6):717-26. doi: 10.1097/JCP.0b013e31823607f6. J Clin Psychopharmacol. 2011. PMID: 22005052 Clinical Trial.
-
Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.Br J Clin Pharmacol. 2002 Jun;53(6):613-28. doi: 10.1046/j.1365-2125.2002.01609.x. Br J Clin Pharmacol. 2002. PMID: 12047486 Free PMC article. Clinical Trial.
-
Pharmacology of ayahuasca administered in two repeated doses.Psychopharmacology (Berl). 2012 Feb;219(4):1039-53. doi: 10.1007/s00213-011-2434-x. Epub 2011 Aug 13. Psychopharmacology (Berl). 2012. PMID: 21842159 Clinical Trial.
-
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.Curr Neuropharmacol. 2019;17(2):108-128. doi: 10.2174/1570159X16666180125095902. Curr Neuropharmacol. 2019. PMID: 29366418 Free PMC article. Review.
-
Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.Pharmacol Ther. 2004 May;102(2):111-29. doi: 10.1016/j.pharmthera.2004.03.002. Pharmacol Ther. 2004. PMID: 15163593 Review.
Cited by
-
Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies.Front Pain Res (Lausanne). 2024 Apr 19;5:1346053. doi: 10.3389/fpain.2024.1346053. eCollection 2024. Front Pain Res (Lausanne). 2024. PMID: 38706873 Free PMC article.
-
LSD increases sleep duration the night after microdosing.Transl Psychiatry. 2024 Apr 15;14(1):191. doi: 10.1038/s41398-024-02900-4. Transl Psychiatry. 2024. PMID: 38622150 Free PMC article. Clinical Trial.
-
Bedside to bench: the outlook for psychedelic research.Front Pharmacol. 2023 Oct 2;14:1240295. doi: 10.3389/fphar.2023.1240295. eCollection 2023. Front Pharmacol. 2023. PMID: 37869749 Free PMC article. Review.
-
A Systematic Review on the Therapeutic Effects of Ayahuasca.Plants (Basel). 2023 Jul 7;12(13):2573. doi: 10.3390/plants12132573. Plants (Basel). 2023. PMID: 37447135 Free PMC article. Review.
-
Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey.PLOS Glob Public Health. 2022 Nov 16;2(11):e0000438. doi: 10.1371/journal.pgph.0000438. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962494 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources